David Loy

AdventHealth Celebration, University of Florida

Papers

3

Total Citations

36

H-Index

3

About

David Loy is a urologic surgeon and researcher whose work centers on advancing robotic-assisted surgical techniques for prostate cancer, with a particular focus on optimizing patient outcomes in radical prostatectomy. His major contributions include pioneering comparative analyses of robotic platforms, most notably his 2023 study comparing the da Vinci SP and da Vinci Xi systems, which demonstrated key differences in intraoperative and postoperative outcomes and has already garnered 18 citations. Loy has also established the safety of performing simultaneous hernia repair during robotic-assisted radical prostatectomy, showing low rates of mesh-related complications in a 2023 study (11 citations). His research further examines the long-term functional and oncological impacts of robotic prostatectomy in the context of shifting PSA screening guidelines, with a 2024 study (7 citations) evaluating outcomes a decade after the USPSTF’s controversial 2012 recommendations against routine screening. By addressing both technological innovation and evolving clinical paradigms, Loy’s work provides critical guidance for surgeons navigating the intersection of robotics, patient safety, and public health policy.

Research Focus

Key Achievements

3
H-Index
3
Papers
36
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Comparison between intra- and postoperative outcomes of the da Vinci SP and da Vinci Xi robotic platforms in patients undergoing radical prostatectomy
18 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: AdventHealth Celebration, University of Florida

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago